Clinical trial No longer in our active list Interventional Ages 18 and up

Using dexmedetomidine during surgery for brain aneurysms

Official title: Role of Intraoperative Dexmedetomidine Infusion in Endovascular Intervention for Aneurysmal Subarachnoid Hemorrhage: A Randomized Controlled Trial

Run by Tanta University · NCT06352593 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study is testing if giving dexmedetomidine during surgery for brain aneurysms can help protect the brain and improve recovery compared to a placebo.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment90 (estimated)
SponsorTanta University
Academic / other
Locations1 site (Tanta, ElGharbia)
Trial IDNCT06352593 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults over 18 years old with unruptured subarachnoid hemorrhage undergoing endovascular intervention.

Probably not a fit

Patients with subarachnoid hemorrhage from non-aneurysmal causes or those with significant comorbidities may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effects of intraoperative dexmedetomidine infusion during endovascular interventions for patients with aneurysmal subarachnoid hemorrhage. Aneurysmal subarachnoid hemorrhage is a critical condition that can lead to severe neurological complications, primarily due to cerebral vasospasm. Dexmedetomidine, a selective α-2 adrenergic receptor agonist, is investigated for its neuroprotective properties and ability to improve cerebral perfusion and reduce cellular injury. The study compares the outcomes of patients receiving dexmedetomidine versus a placebo during their surgical procedure.

Why it matters

Potential benefit: If successful, this approach could enhance patient recovery and reduce neurological complications following aneurysmal subarachnoid hemorrhage.

How similar studies have gone: While the use of dexmedetomidine has shown promise in other contexts, this specific application in aneurysmal subarachnoid hemorrhage is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Aged \>18 years.
* Both sexes.
* American Society of Anesthesiologists (ASA) I-III
* Unruptured subarachnoid hemorrhage (SAH) confirmed by digital subtraction catheter angiography (DSA) undergoing endovascular intervention with general anesthesia.

Exclusion Criteria:

* Subarachnoid hemorrhage (SAH) from a lesion other than a ruptured saccular aneurysm.
* Intraventricular or intracerebral blood in the absence of localized thick or diffuse Subarachnoid hemorrhage (SAH).
* No or localized thin subarachnoid hemorrhage (SAH) on computed tomography (CT).
* Cerebral vasospasm on admission digital subtraction catheter angiography (DSA).
* Hypotension (systolic blood pressure 90 mm Hg) refractory to fluid therapy.
* Neurogenic pulmonary edema.
* Cardiac failure requiring inotropic support.
* Severe or unstable concomitant condition or disease or chronic condition.
* Kidney and/or liver disease.
* Prior cerebral damage on computed tomography (CT) scan such as stroke (\>2 cm maximum diameter).
* Pregnancy.
* Traumatic brain injury.
* Previously treated cerebral aneurysm.
* Arterial venous malformation.
* Pre-existing cerebrovascular disorder that will affect diagnosis and evaluation of Subarachnoid hemorrhage (SAH).
* Ischemic heart disease or second or third-degree atrioventricular block.
* Long-term abuse of alcohol, opioids, or sedative-hypnotic drugs.
* Obesity (body mass index \[BMI\] \>30 kg/m2).

Where it's running

  • Tanta University Hospitals
    Tanta, ElGharbia, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.